van Berlo-van de Laar IRF, Gedik A, van ‘t Riet E, de Meijer A, Taxis K, Jansman FGA. Identifying patients with metformin associated lactic acidosis in the emergency department. Int J Clin Pharm. 2020 Oct; 42(5): 1286-–1292.

Lalau JD, Kajbaf F, Protti A, Christensen MM, De Broe ME, Wiernsperger N. Metformin-associated lactic acidosis (MALA): Moving towards a new paradigm. Diabetes Obes Metab. 2017 Nov; 19(11): 1502-–1512.

Ávila E, Roessler B E. MALA: Acidosis láctica asociado al uso de metformina, una revisión a propósito de casos clínicos [MALA: Lactic acidosis associated with the use of metformin, review of clinical cases]. Rev Med Chil. 2023 May; 151(5): 618-–627. Spani

Gordon, L., Pasquier, M., Brugger, H. -2014752179 et al. Autoresuscitation (Lazarus phenomenon) after termination of cardiopulmonary resuscitation –- a scoping review. -2014752179 Scand J Trauma Resusc Emerg Med -2014752178 28, 14 (2020). https://doi.org/

Kuisma M, Salo A, Puolakka J, Nurmi J, Kirves H, Väyrynen T, Boyd J. Delayed return of spontaneous circulation (the Lazarus phenomenon) after cessation of out-of-hospital cardiopulmonary resuscitation. Resuscitation. Sep 2017 Sep; 118: 107–-111. doi: 10.1

Dhanani S, Ward R, Hornby L, Barrowman NJ, Hornby K, Shemie SD. Survey of determination of death after cardiac arrest by intensive care physicians. Crit Care Med. 2012; 40: 1449-–55.

Klubo-Gwiezdzinska, J. and L. Wartofsky, Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment. Polish archives of internal medicine, 2022. 132(3).

Akamizu, T. and N. Amino, Hashimoto’s thyroiditis, K.R. In Endotext; Feingold, Anawalt, B., Boyce, A., Chrousos, G., de Herder,W.W., Dhatariya, K., Dungan, K., Hershman, J.M., Hofland, J., Kalra, S., Eds.; MDTex: Dartmouth, MA, USA, 2017., Editor. 2015.

Ahmad, A.M., et al., Effects of aerobic, resistance, and combined training on thyroid function and quality of life in hypothyroidism. A randomized controlled trial. Complementary Therapies in Clinical Practice, 2023.

Munakomi S, Singh AK. Neurofibromatosis Type 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026. Available from: https://www.ncbi.nlm.nih.gov/ books/NBK459358/

Reviron-Rabec L, Girerd B, Seferian A, Campbell K, Brosseau S, Bergot E, et al. Pulmonary complications of type 1 neurofibromatosis. Rev Mal Respir. 2016; 33(6): 460–473. doi:10.1016/j.rmr.2014.09.010

Alves Júnior SF, Zanetti G, Alves de Melo AS, Rodrigues RS, Marchiori E. Neurofibromatosis type 1: state-of-the-art review with emphasis on pulmonary involvement. Respir Med. 2019; 149: 9–15. doi:10.1016/j.rmed.2019.01.002